CVE-2026-52866

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization

CVSS 7.1 HIGHEPSS 0.2%CWE-862

Vexday Risk Score

21Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 7.1EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch —

Lifecycle

18 Jun 2026Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N

Affected products

Apollo Pharmacy · Blood Glucose Monitoring System (Model No. APG-01 BT)

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →

References

https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json https://www.apollopharmacy.in/contact-us https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01 https://www.cisa.gov/news-events/news/understanding-bluetooth-technology